Search

Search Constraints

You searched for: Author/Creator Giotta, Francesco

Search Results

2. 7 DOACs: a new skyline in cancer-associated thrombosis resistant to heparin. A clinical case of seminoma in BEP chemotherapy protocol solved with edoxaban. (8th December 2021)

3. A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study. Issue 2 (1st February 2019)

4. Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer. (3rd July 2022)

5. Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study. (April 2014)

6. Cancer-Associated Thrombosis: Not All Low-Molecular-Weight Heparins Are the Same, Focus on Tinzaparin, A Narrative Review. (19th July 2022)

8. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting. Issue 7 (7th August 2019)

10. Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes. (14th October 2016)